The study of pentoxifylline drug effects on renal apoptosis and BCL-2 gene expression changes following Ischemic Reperfusion injury in rat

Iranian Journal of Pharmaceutical Research

Volumn 13, Issue 1, 2014, Pages 181-189

  Hashemi, Mehrdad ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

BCL 2 gene; Ischemia; Pentoxyfylline; Real time PCR

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PENTOXIFYLLINE; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; GENE EXPRESSION; HISTOPATHOLOGY; ISCHEMIA; KIDNEY ARTERY STENOSIS; KIDNEY CELL; KIDNEY INJURY; MALE; NICK END LABELING; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENAL PROTECTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION; SEQUENCE ANALYSIS; VEIN OCCLUSION;

EID: 84903612555     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Abramson SB and Weissmann G. The mechanisms of action of non steroidal anti-inflammatory drugs. Arthr. Rheum. J. (1989) 32: 1-7.
2. Neumann J, Sauerzweig S and Ronicke R. Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege. J. Neurosci. (2008) 23: 5965-5975.
3. Kanduc D, Mittelman A, Serpico R, Sinigaglia E, Sinha AA, Natale C, Santacroce R, Di Corcia MG, Lucchese A, Dini L, Pani P, Santacroce S, Simone S, Bucci R and Farber E. Cell death: apoptosis versus necrosis. Int. J. Oncol. (2002) 21: 165-170.
4. Jover-Mengual T, Zukin RS and Etgen AM. MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. Endocrinol. (2007) 148: 1131-1143.
5. Hu X, Zhang Y and Zeng F. Effects of sodium B-aescin on expression of adhesion molecules and migration of neutrophils after middle cerebral artery occlusion in rats. Acta. Pharmacol. Sin. (2004) 25: 869-875.
6. Devarajan P. Cellular and molecular derangements in acute tubular necrosis. Curr. Opin. Pediatr. (2005) 17: 193-199.
7. Francischetti I, Moreno JB, Scholz M and Yoshida WB. Leukocytes and the inflammatory response in ischemia-reperfusion injury. Rev. Bras. Cir. Cardiovasc. (2010) 25: 575-584.
8. Harukuni I and Bhardwaj A. Mechanisms of brain injury after global cerebral ischemia. Neurol. Clin. (2006) 24: 1-21.
9. Vanden Berghe T, Vanlangenakker N, Parthoens E, Deckers W, Devos M, Festjens N, Guerin CJ, Brunk UT, Declercq W and Vandenabeele P. Necroptosis necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Different. (2010) 17: 922-930.
10. Friedewald JJ and Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int. (2004) 66: 486-490.
11. Chen Q, Moghaddas S, Hoppel CL and Lesnefsky EJ. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am. J. Physiol. Cell Physiol. (2008) 294: 460-466.
12. Lakhan Sh, Kirchgessner A and Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. (2009) 7: 97.
13. Mallick IH, Yang W, Winslet MC and Seifalian AM. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig. Dis. Sci. (2004) 49: 1359-1377.
14. Arumugam TV, Shiels IA, Woodruff TM, Granger DN and Taylor SM. The role of the complement system in ischemia-reperfusion injury. Shock (2004) 21: 401-409.
15. Bernhard Dorweiler. Diethardpruefer Ischemia- reperfusion injury pathophysiology and clinical implications. Eur. J. Trauma. Emergency Surg. (2007) 33: 600-612.
16. Nekooeian AA, Vakili A and Dehghani GA. Pre- ischemic treatment of pentoxifylline reduces infarct volumes in transient focol cerebral ischemia in the rat. Iran. J. Med. Sci. (2005) 30: 231-234.
17. Cerqueira NF, Hussni CA and Yoshida WB. Pathophysiology of mesenteria ischemia /reperfusion. Acta. Cirurgica. Bras. (2005) 20: 1678-2674.
18. Banfi C and Sironi L. Pentoxifylline prevent spontaneous brain ischemia in stroke-prone rats. J. Pharmacol. Experiment. Ther. (2004) 21: 112-134.
19. Teruya R, Fagundes DJ, Oshima CT, Brasileiro JL, Marks G, Ynouye CM and Simões MJ. The effects of pentoxifylline into the kidneys of rats in a model of unilateral hindlimb ischemia/reperfusion injury. Acta. Cir. Bras. (2008) 23: 29-35.
20. Inal M, Kanbak G and Adali M. Prevention of ischemia-reperfusion-induced oxidative injury in liver by Allopurinol and pentoxifylline. Transplantationsmedizin (2006) 18: 29-32
21. th ed. W. B. Saunders Company, Philadelphia (1989) 1-50.
22. Hidehisa Kitada, Atsushi Sugitani, Hirofumi Yamamoto, Naoki Otomo, Yasuhiro Okabe, Shigetaka Inoue, Ken-Ichi Nishiyama, Takashi Morisak and Masao Tanaka Attenuation of renal ischemia reperfusion injury by FR167653 in dogs. Surgery (2002) 131: 654-662.
23. Kelly KJ, Williams WW, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC and Bonventre JV. Intercellular adhesion molecule- 1- deficient mice are protected against ischemic renal injury. J. Clin. Invest. (1996) 97: 1056-1063.
24. Daem MA, Wan de Ven MW, Heineman E and Buurman WA. Involvement of endogenous interleukin-10 and tumor necrosis factor- alfa in renal ischemia- reperfusion injury. Transplantation (1999) 67: 792-800.
25. Basile DP, Liapis H and Hammerman MR. Expression of BCL-2 and bax in regenerating rat renal tubules following ischemia injure. Am. J. Physiol. (1997) 272: 640-47.
26. Donnahoo KK, Shames BD, Harken AH and Meldrum DR. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J. Urol. (1999) 162: 196-203.
27. Jefayri MK, Grace PA and Mathie RT. Attenuation of reperfusion injure by renal schemic preconditioning: the role of nitric oxide. BJU. Int. (2000) 85: 1007-1013.
28. Zabel P, Schonharting MM, Schade UF and Schlaak M. Effects of pentoxifylline in endoxinemia in human volunteers. Prog. Biol. Res. (1991) 367: 207-213.
29. Koeing M, Cathebras P, Guy C and Rousset H. Pentoxifylline: a cheap substitute for anti-TNFα agents. La Revue demedicine interne. (2006) 27: 400-405.
30. Savic V, Vlahovic P, Djordjevic V, Mitic-Zlatkovic M and Avramovic V. Nephroprotective effects of pentoxifylline inexperimental myoglobinuric acute renal failure. Pathol. Biol. J. (2002) 50: 599-607.
31. Karkar AM, Smith J and Pusey CD. Prevention and treatment of experimental crescentric glomerulonephritis by blocking tumor necrosis factor- alfa. Nephrol. Dial. Transplant. (2001) 16: 518-524.
32. Yakubov E and Gottlieb M. Overexpression of genes in the CA1 hippocampus region of adult rat following episodes of global ischemia. Brain Res. Mol. Brain Res. (2004) 127: 10-26.
33. Gob́ EG, Zhang X, Willgoss DA, Schoch E, Hogg NA and Endre Z. Relationship between expression of BCL-2 genes and growth factors in ischemic acute renal failure in the rat. J. Am. Soc. Nephrol. (2000) 11: 454-467.
34. Chien C, Lee P, Chien C, Ma M, Lai M and Hsu S. De novo demonstration and co-ocalization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/ reperfusion. J. Am. Soc. Nephrol. (2001) 12: 973-982.
35. Khazaei Koohpar Z, Hashemi M, Mahdian R and Parivar K. The effect of pentoxifylline on BCL-2 gene expression changes in hippocampus after long-term use of ecstasy in wistar rats. Iran. J. Pharm. Res. (2013) 12: 521-527.
36. Sari S, Hashemi M, Mahdian R, Parivar K and Rezayat M. The effect of pentoxifylline on BCL-2 gene expression changes in hippocampus after ischemia-reperfusion in Wister rats by a quantitative RT-PCR method. Iran. J. Pharm. Res. (2013) 12: 495-501.